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Abstract
Background: Effectiveness of Internet-based self-management in patients with asthma has been shown, but its cost-
effectiveness is unknown. We conducted a cost-effectiveness analysis of Internet-based asthma self-management compared
with usual care.
Methodology and Principal Findings: Cost-effectiveness analysis alongside a randomized controlled trial, with 12 months
follow-up. Patients were aged 18 to 50 year and had physician diagnosed asthma. The Internet-based self-management
program involved weekly on-line monitoring of asthma control with self-treatment advice, remote Web communications,
and Internet-based information. We determined quality adjusted life years (QALYs) as measured by the EuroQol-5D and
costs for health care use and absenteeism. We performed a detailed cost price analysis for the primary intervention. QALYs
did not statistically significantly differ between the Internet group and usual care: difference 0.024 (95% CI, 20.016 to 0.065).
Costs of the Internet-based intervention were $254 (95% CI, $243 to $265) during the period of 1 year. From a societal
perspective, the cost difference was $641 (95% CI, $21957 to $3240). From a health care perspective, the cost difference was
$37 (95% CI, $2874 to $950). At a willingness-to-pay of $50000 per QALY, the probability that Internet-based self-
management was cost-effective compared to usual care was 62% and 82% from a societal and health care perspective,
respectively.
Conclusions: Internet-based self-management of asthma can be as effective as current asthma care and costs are similar.
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Introduction
Asthma is a chronic, inflammatory disorder of the airways
clinically characterized by respiratory symptoms such as wheeze,
cough, dyspnoea, chest tightness and impaired lung function [1,2].
Treatment for asthma is aimed at improving asthma control, i.e.
reducing current symptoms and need for short-acting bronchodi-
lation, improving lung function and preventing future exacerba-
tions [1–3].
In the past decade, the care for asthma patients has shifted from
physician-managed care to guided self-management. Guided self-
management includes asthma education, self-monitoring of
symptoms and/or lung function and adjustment of treatment
according to an action plan guided by a health care professional
(not necessarily a physician). Self-management has been shown to
improve asthma control and quality of life and reduce health care
utilization and sometimes improve lung function [4].
Besides clinical effectiveness, the implementation of new disease
management strategies requires an economic evaluation to
determine whether the clinical benefits are gained at reasonable
costs. Several cost evaluations have compared paper-and-pencil
self-management plans to usual care in asthma [5–11], but only a
few compared costs to quality of life [10–11]. Most of these
economic evaluations found that written self-management plans
for asthma were likely to be cost-effective compared to usual
physician provided care. However, the implementation of paper-
and-pencil self-management plans is hampered by patients’ and
doctors’ reluctance to use written diaries [12].
Implementation of guided self-management programs may be
enhanced by the use of Internet-based technologies, particularly in
remote and underserved areas. In a recently conducted random-
ized controlled trial we have shown that Internet-based self-
management is feasible and provides better clinical outcomes
compared to usual physician provided care with regard to asthma
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function [13]. Although previous trials have also evaluated the
clinical effects of Internet-based self-management in adults [14]
and children [15,16], so far, no economic evaluations have been
conducted. We therefore carried out a cost-utility analysis,
comparing quality of life with societal and health care costs
during one year, to determine whether the clinical benefits gained
with Internet-based self-management are attained at reasonable
costs.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Protocol S1, Checklist
S1, and Flowchart S1.
Ethics statement
The study was approved by the Medical Ethics Committee of
the Leiden University Medical Center. All participants gave their
written consent.
Setting and Participants
Two hundred patients participated in a 12-month multicenter,
non-blinded, randomized controlled trial. Patients were recruited
from 37 general practices (69 General Practitioners) in the Leiden
and The Hague area and the Outpatient Clinic of the Department
of Pulmonology at the Leiden University Medical Center, The
Netherlands over the period from September 2005 to September
2006 [13]. We included patients with physician diagnosed asthma
as coded according to the International Classification of Primary
Care in the electronic medical record [17], aged 18–50 years, with
a prescription of inhaled corticosteroids for at least three months in
the previous year, access to Internet at home, mastery of the Dutch
language and without serious comorbid conditions that interfered
with asthma treatment. Patients on maintenance oral glucocorti-
costeroid treatment were excluded. All participants gave their
written consent.
Details of the randomization and intervention have been
described previously [13]. Briefly, the 200 patients were randomly
assigned to Internet-based self-management as an adjunct to usual
care (Internet group: 101 patients) or to usual physician-provided
care alone (usual care group: 99 patients). Allocation took place by
computer after collection of the baseline data, ensuring conceal-
ment of allocation. The Internet-based self-management program
included weekly monitoring of asthma control and lung function,
immediate treatment advice according to a computerized personal
action plan after completing the validated Asthma Control
Questionnaire on the Internet [18], on-line education and
group-based education, and remote Web communication with a
specialized asthma nurse.
Utilities and QALYs
Utilities express the valuation of health-related quality of life on
a scale from zero (death) to one (perfect health). Patients described
their health-related quality of life using the EuroQol classification
system (EQ-5D) [19], from which we calculated their utilities over
time using the British tariff [20]. The area under the utility curve is
known as quality-adjusted life years (QALY) and was used as the
primary outcome measure for the cost-effectiveness analysis.
Patients additionally valued their own health status on a visual
analogue scale (VAS). This scale from the patient perspective is
potentially more responsive to change than other generic quality of
life instruments, but is not the best choice for economic evaluations
from a societal perspective [21]. The VAS scale was transformed
to a utility scale using the power transformation 12(1-VAS/
100)
1.61 [22].
We obtained utility measurements at baseline, 3 and 12 months.
For EQ-5D measurements 6.5%, 10% and 8.5% were missing and
for visual analogue measurements 7%, 10% and 9% were missing
at 0, 3 and 12 months, respectively. To correct for possibly
selective non-response, missing measurements were replaced by 5
imputed values based on switching regression [23,24] with
regression variables randomisation group, age, sex, asthma control
at baseline and available utility measures at all time points.
Costs
We distinguished three major cost categories: intervention costs,
other health care costs and productivity costs [10,11]. Intervention
costs consisted of materials (software support, electronic spirom-
eter), personnel and patient costs (travel, time, Internet and text
messaging costs). Other health care costs included contacts
(including face-to-face, telephonic and home contacts) with health
care professionals (general practitioners, chest physician, other
specialists, physiotherapists, psychologists, complementary care
and other paramedical professionals), emergency room visits,
hospital admissions and both asthma and non-asthma medication.
Productivity costs consisted of hours of absence from work.
Patients reported their use of health care resources and the
hours of absence from work using a quarterly cost-questionnaire.
We used Dutch standard prices for units of resource use (contacts
with health care professionals, hospital admissions and drug
prescriptions) and hours of absenteeism, designed to represent
societal costs and to standardize economic evaluations [25,26].
Hours of absenteeism were converted to costs by multiplying them
with the age and gender average hourly wage [25]. Details of the
drugs used were derived from pharmacy records. All prices were
converted to the price level of 2007 according the general Dutch
consumer price index [27] and converted to US dollars using the
purchasing power parity index (J1=$1.131) [28]. Because of the
one-year time horizon, costs were not discounted.
Cost-questionnaires were scheduled to be handed in at 3, 6, 9
and 12 months. Of these quarterly questionnaires, 10%, 14%,
19% and 9% were missing, respectively. Pharmacy records were
available for 182 patients (91%). Missing cost-questionnaire and
pharmacy record were imputed using multiple imputation, as
previously described under ‘Utilities and QALYs’.
Statistical Analysis
Differences and statistical uncertainty of QALYs and costs were
calculated using non-parametric bootstrap estimation with 5000
random samples (1000 from each of the 5 imputations).
Differences in costs resulted from differences in volumes rather
than differences in unit costs, since we used standard prices for
units of resource use and hours of absenteeism. We estimated the
intervention effect by a linear regression model with randomisa-
tion group as only independent variable, combining the 5 multiple
imputation sets using Rubin’s rules [29].
Analyses were carried out with Stata 9.0 (StataCorp, College
Station, TX).
Cost-Effectiveness Analysis
The base case cost-effectiveness analysis compared societal costs
with QALYs gained based on the British EQ-5D over the period
of one year. Because of the limited degree of modeling in this cost
utility analysis, we carried out sensitivity analyses only on the use
of different utility measures (British EQ-5D or Visual Analogue
Scale) and on the included cost categories (societal or healthcare
perspective).
Internet-Based Asthma Self-Management
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using the net benefit approach [30]. The net benefit is defined as l
x DQALY – Dcosts, where l is the willingness to pay for a gain of
one quality-adjusted life year. This way, the observed QALY
difference is reformulated into a monetary difference. The
uncertainty about cost-effectiveness was graphically shown by
plotting the bootstrapped incremental costs and QALY estimates
in the cost-effectiveness plane (200 estimated pairs for each of the 5
imputed datasets) (figure 1). In a cost-effectiveness acceptability
curve we graphed the probability (12[one sided] P value) that the
Internet-based self-management program was cost-effective (i.e.
had higher net benefit) compared with usual care, as a function of
l for a range of l between 0 and 200000 (figure 2). We highlighted
this probability at commonly cited willingness-to-pay values of
$50000 and $100000 per QALY [31].
Results
The Internet group and usual care group consisted of 101 and
99 participants, respectively. Mean age of the sample was 37 years
and 70% of the participants were women (table 1). At baseline,
asthma related quality of life, asthma control and medication use
were similar for the two randomization groups.
Utilities and QALYs
At baseline, the utilities according to the EQ-5D did not
statistically significantly differ between the Internet group and the
usual care group. EQ-5D utilities did not reach a statistical
significant difference throughout the study. At 3 months and 12
months the difference in EQ-5D utility was 0.037 (95% CI, 20.007
to 0.081) and 0.006 (95% CI, 20.042 to 0.054), respectively.
Similarly, the difference in quality adjusted life years was not
statistically significant: 0.024 (95% CI, 20.016 to 0.065) (table 2).
Visual analogue scale utilities were not statistically significantly
different throughout the study. At 3 and 12 months the difference
in visual analogue scale utility was 0.012 (95% CI, 20.026 to
0.050) and 0.013 (95% CI, 20.015 to 0.040), respectively. The
difference in quality of life years based on the visual analogue scale
was estimated to be 0.007 (95% CI, 20.017 to 0.032) (table 2).
Costs
The total intervention costs were estimated at $25675, which is
$254 (95% CI, $243 to $265) per patient (table 3). The highest cost
components of the Internet-based intervention were software
support ($7917) and the patients’ time costs ($5380 for monitoring
time and $5106 for attending the education sessions).
The difference in other health care costs was not statistically
significant: $-217 (95% CI, $21117 to $682) (table 4). Patients in the
Internet group had fewer contacts with physiotherapists ($2120,
p=0.03), but not with other health care providers, e.g. general
practitioners ($269, p=0.18). Similarly differences in costs for
medication did not reach statistical difference (table 4). The difference
in total health care costs was negligible: $37 (95% CI, $2874 to $950).
Patients in the Internet group reported 114 hours of absence
from work compared to 98 hours for patients in the usual care
group. The 16 hours difference in absenteeism was estimated to be
equivalent to $604 (95% CI, $21430 to $2637) in monetary terms.
The difference in societal costs (i.e. health care costs plus costs due
to absenteeism) was therefore estimated at $641 (95% CI, $21957
to $3240) in favor of usual care.
Cost-utility analysis
The estimates of the cost differences and QALY differences
were both not-statistically significant. The cost-utility ratio, based
on these point estimates, was $26700 per QALY. The probability
that Internet-based self-management was both more effective and
less costly than usual care (dominant) was 30%. The probability
that it was less effective, but more costly (dominated) was 10%
(figure 1). Due to statistical uncertainty of both costs and QALYs,
the probability that Internet-based self-management is cost-
effective compared to usual care depends on the willingness-to-
pay per QALY. This probability was 62% at $50000 per QALY
and 74% at $100000 per QALY (figure 1 and 2).
From a health care perspective, the lower health care costs
result in a cost-utility ratio of $1500 per QALY. The probability
that Internet-based self-management is cost-effective from a health
care perspective was 82% at $50000 per QALY and 86% at
$100000 per QALY (figure 1 and 2).
QALYs gained, based on the visual analogue scale, were less
than those based on the EQ-5D. The probability that Internet-
based self-management is cost-effective based on visual analogue
scale QALYs was 49% and 60% at $50000 and $100000 per
QALY from a societal perspective and was 71% and 75% at
$50000 and $100000 per QALY from a health care respectively.
Discussion
In this study we evaluated the cost-effectiveness of a new disease
management strategy, Internet-based self-management, for pa-
tients with asthma. The QALY and cost differences, 0.024 and $
641 respectively, between Internet based-self management and
usual care were not statistically significant during a follow-up
period of 1 year. Both the estimation of QALYs gained and the
calculated expenses showed considerable uncertainty, which is
displayed by the cost-effectiveness planes. The estimated cost-
utility ratio was $26700 per QALY, which is generally considered
acceptable [32]. At a commonly cited willingness-to-pay threshold
of $50000 per QALY [31] the Internet-based self-management
intervention had a probability of 62% and 82% to be cost-effective
compared to usual care from a societal perspective and health care
perspective, respectively.
We have previously shown substantial and statistically signifi-
cant clinical effects in favor of Internet-based self-management
with regard to asthma related quality of life, asthma control and
lung function [13,33]. Although the utility outcomes presented in
the current study point in the same direction (i.e. in favor of
Internet-based self-management) as the clinical outcomes, their
statistical significance is less evident. There are two main reasons
that may explain this finding. First, generic quality of life
measures, such as the EQ-5D, must be distinguished from
disease-specific quality of life measures, such as the Asthma
Quality of Life Questionnaire [33]. The latter is well known to be
responsive to change [21]. However, generic preference-based
instruments may differentiate between the highest en lowest levels
of asthma control, but are less able to discriminate between
moderate levels [34,35]. The baseline asthma control scores found
in our primary care study population can be classified as
moderately or partly controlled asthma and substantial improve-
ments in disease-specific quality of life may have been missed by
the generic instruments. Second, the absence of a statistically
significant difference in our primary utility measure may reflect a
lack of statistical power, since our trial was powered to detect a
statistical difference in the primary outcome measure, asthma
related quality of life, and not explicitly to detect differences in
generic preference-based utility measures [13,36].
The intervention costs of $254 per patient were similar to
intervention costs of a paper-and-pencil asthma self-management
program [10], but were half of the costs of intensive nurse-led
Internet-Based Asthma Self-Management
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technological innovation (software support, electronic spirometer,
Internet and mobile phone costs) were only about 40% of the total
intervention costs. The fixed technological costs of software
support constituted about one third of the intervention costs, so
a considerable increase in the number of users could reduce the
cost per user by one third. Moreover, the calculations were based
on costs during the one-year randomized controlled trial. Asthma
Figure 1. Cost-effectiveness planes. Uncertainty about cost-effectiveness of the asthma internet-based self-management program compared
with usual asthma care (showing the 1000 bootstrapped estimates). Circles and triangles represent the incremental societal and health care costs,
respectively, plotted against the incremental quality adjusted life years (QALY) (intervention minus usual care). The south-east quadrant indicates that
internet-based self-management intervention dominates usual care (i.e. effectiveness is higher and costs are lower), the north-west quadrant
indicates that usual care dominates the intervention. The points below the dashed diagonal lines are cost-effective at a willingness to pay threshold
of $50000 and $100000 per QALY, respectively.
doi:10.1371/journal.pone.0027108.g001
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PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e27108Figure 2. Cost-effectiveness acceptability curves. The probability that Internet-based self-management is cost-effective compared to usual
care depending on the willingness-to-pay per QALY from a societal perspective (solid line) and health care perspective (dashed line).
doi:10.1371/journal.pone.0027108.g002
Table 1. Baseline characteristics.
Usual Care Group
(n=99)
Internet Group
(n=101)
Women, 71% 68%
Age, years 37 (18–50) 36 (19–50)
Asthma duration, years 18 (0–47) 15 (1–47)
Education level
Low 14% 11%
Middle 33% 37%
High 53% 52%
Care provider
General practitioner 80% 79%
Chest physician 20% 21%
FEV1 (pre-bronchodilator), L 3.13 (1.56–5.23) 3.08 (1.14–5.19)
FEV1 (pre-bronchodilator), % predicted 90 (53–118) 88 (34–133)
Inhaled corticosteroid dose, mg/day 517 (0–2000) 494 (0–1000)
Inhaled long-acting b
2-agonist, % of patients 60% 59%
Leukotriene modifier, % of patients 2% 3%
Clinical outcomes
Asthma Quality of Life Questionnaire* 5.79 (3.03–7.00) 5.73 (3.66–6.94)
Asthma Control Questionnaire{ 1.11 (0–3.86) 1.12 (0.07–3.22)
Patient utilities{
EQ-5D utility 0.89 (20.06–1.00) 0.91 (0.49–1.00)
EQ-5D visual analogue scale 74 (35–100) 73 (20–100)
Data are mean (range) unless otherwise indicated.
*Range 1 (worst) – 7 (best) [19].
{Range 0 (best) – 6 (worst) [18].
{EQ-5D=EuroQol questionnaire, 5 dimensions [20]. Parts of this table were published previously [13].
doi:10.1371/journal.pone.0027108.t001
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horizon have shown that intervention costs decrease after the first
year [10,37]. In our study, costs for education sessions only apply
to the first year, thus reducing costs in later years by about a
quarter.
Differences in other health care costs should be interpreted with
caution, since almost all components showed statistically non-
significant differences. Only the reduction in contacts with
physiotherapists were statistically significant, suggesting that
patients in the Internet group with better asthma control are less
in need for physiotherapy. The cost of drugs for asthma show
small decreases in short-acting b2-agonists and inhaled cortico-
steroids alone, but increases in combination therapy (inhaled
corticosteroids plus long-acting b2-agonists) and leukotriene
antagonists in the self-management group. The increase in
volumes and costs of asthma controller medication accompanied
by a decrease in reliever medication might have contributed to
improved clinical outcomes in favor of Internet-based self-
management.
Our study had several limitations. First, quality adjusted life
year estimates were calculated from only two follow-up measure-
ments. More measurements would possibly have resulted in more
accurate QALY estimates, but we limited the number of follow-up
measures in order to minimize the awareness of participating in a
clinical trial among patients in the usual care group. Second,
patients were inevitably aware of the allocated group, which may
have influenced their utility ratings. Therefore, the effects observed
may be due to unblinding. On the other hand, the influence of
unblinded groups in pragmatic trials might be regarded as part of
the intervention, since all interventions implemented in daily
Table 2. Utilities at 0, 3 and 12 months and QALYs*.
Variable Usual Care Group Internet Group Difference (95% CI) P value
EQ-5D
0 months 0.89 0.91 0.026 (20.024 to 0.076) 0.31
3 months 0.89 0.93 0.037 (20.007 to 0.081) 0.099
12 months 0.91 0.92 0.006 (20.042 to 0.054) 0.80
QALYs 0.90 0.92 0.024 (20.016 to 0.065) 0.25
Visual analogue scale{
0 months 0.87 0.86 20.013 (20.045 to 0.019) 0.43
3 months 0.87 0.89 0.012 (20.026 to 0.050) 0.54
12 months 0.88 0.89 0.013 (20.015 to 0.040) 0.37
QALYs 0.88 0.88 0.007 (20.017 to 0.032) 0.57
*Values are summary estimates of the 5 data sets obtained by multiple imputation, combined using Rubin’s rules.
{Transformed using the power transformation 12(1-VAS/100)
1.61 [23].
doi:10.1371/journal.pone.0027108.t002
Table 3. Implementation costs ($) of Internet-based self-management intervention.
Component of cost Cost per unit Number of units Total cost
Materials
software support 7917/yr 1 7917
electronic spirometer 19.22/device 101 1942
Personnel
development educational aids 26/hr 16 412
education sessions 26/hr 30 780
data review and patient communication 26/hr 91 2351
Patient costs
travel costs for sessions 6/session 258 1465
time costs for sessions (incl. travel time) 20/session 258 5106
time costs for monitoring* 0.50/log in 10873 5380
Internet log in costs{ 0.0016/log in 9374 15
mobile phone costs{ 0.20/message 1499 305
Total implementation costs 25675
Total implementation costs per patient 254
*Monitoring time was estimated at 3 minutes per log in and valued at $10 per hour, i.e. the Dutch standard price for unpaid labour [27]. Number of units was obtained
from Internet log files.
{Internet costs were valued at $23 per month.
{Mobile phone costs were valued at $0.20 per message.
doi:10.1371/journal.pone.0027108.t003
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was limited to one year. As pointed out above a longer duration
would probably have resulted in reduced intervention cost
estimates after one year. It is, however, unknown how EQ-5D
utility scores will progress after one year.
New cost-effective disease management strategies for asthma are
required to face up to the global burden of asthma. Internet-based
self-management is an innovative and effective management
strategy in adults with asthma that improves clinical outcomes
[13]. This Internet-based strategy can be as effective as current
asthma care with regard to quality of life and costs are similar.
Future implementation studies ought to add other quality of life
measures in order to reveal potentially more subtle differences.
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